The Leiden Academic Centre for Drug Research (LACDR) is closely connected to the education of our biopharmaceutical students, providing both courses and immersive internship projects. Among these is the Bachelor Research Project (BOO), which offers many students their first real scientific experience…

As a bachelor student of Bio-Pharmaceutical Sciences, Femke Vlaswinkel wrote a research proposal she was allowed to carry out in her master’s BPS. Femke subsequently graduated with honors. Her research was published in the journal Scientific Reports, she won an award from the Dutch Pharmacy Society…

PhD defence

The fact that corona has created a wave of creativity is evident when walking around in the lab of pharmacologist Coen van Hasselt from the LACDR. Suddenly there were far fewer master's students permitted in the lab for their research. So Van Hasselt came up with smart solutions to enable lab work to…

Due to the increasing resistance to certain antibiotics, the life-threatening condition sepsis is becoming harder to treat. For her PhD project, Leiden pharmacologist Feiyan Liu used mathematical modeling to find out how antibiotics can be used more effectively to cure sepsis.

When a bacterium becomes more resistant to one antibiotic, it sometimes becomes more sensitive to another. To better understand this interaction, researchers from the Leiden Institute of Biology (IBL) and the Leiden Academic Center for Drug Research (LACDR) under supervision of Daniel Rozen and Coen…

How do you detect people at high risk of heart attacks and strokes? And how can we improve the treatment of atherosclerosis? These are the questions that keep LACDR researcher Marie Depuydt busy. She is investigating the immune cells that contribute to the worsening of atherosclerosis. ‘It's a challenging…

Optimised antibiotic combinations can combat bacteria more effectively while also slowing the development of resistance. Scientists from five European countries are joining forces to identify such combinations and provide tools for others to do the same. The project is led by Professor Coen van Hasselt…

Smart drug carriers, uneven cosmic expansion, and solar energy storage in molecules. These are the topics of three newly awarded NWO-XS grants to researchers at the Faculty of Science.

ICT

How can we better prepare students for their practicals, so that they learn more from them? Marjo de Graauw and her colleagues want to renew science education. Together they will develop interactive teaching materials to introduce students to laboratory courses. They are receiving a SURF grant of €100,000…

On 15 April, our much-beloved and highly respected former colleague Dr Hans Brussee passed away from cancer. In January 2025, Hans began experiencing neck pain. Initially, it appeared to be a herniated disc, but sadly, the diagnosis was soon revised, and his condition proved untreatable. Hans was 77…

On January 1st Jasper Knoester started as our new dean. How is he finding it? What kinds of things is he doing and what does his day look like? In each newsletter Jasper gives a peek into his life as dean.

About one and a half million people worldwide die each year from tuberculosis. For thirty years, therapy with antibiotics has been the same, while it takes far too long and can lead to resistant pathogens. Leiden researchers from four institutes are now joining forces to develop more effective and efficient…

As of this month, Kim Bonger has been appointed Professor of Chemical Biology. As a first-generation academic, she’s especially grateful. ‘I wasn’t exactly a top student at school. I never could’ve imagined this.’

Giving an incorrect answer as a student in a packed lecture hall can be nerve-wracking. But with Pharmacology teacher Rob van Wijk, you don’t need to worry about that. ‘He creates a comfortable and safe atmosphere,’ his students say. They have nominated him for the Leiden Science Teacher Award.

The right medicine in the right dosage for every patient, that is something medical science aspires. 'Personalised medicine' is the term for that. But it does require a lot of research with patient data and that can be hard to get due to privacy legislation. Researchers Laura Zwep and Coen van Hasselt…

Jasper Knoester is the dean of the Faculty of Science. How is he doing? What kinds of things is he doing and what does his day look like? In each newsletter Jasper gives a peek into his life as dean.

Bringing your drug candidates to patients is what many academic chemists dream about, but the road to this goal is long and bumpy. Now, Leiden small molecule nizubaglustat is ready for phase 3 clinical trials. This is thanks to a €132 million funding secured by the biotech spin-out Azafaros.

How should we address our colonial heritage? And how digital and accessible are our collections? Outgoing State Secretary Fleur Gräper spoke with researchers and heritage specialists about this on 25 January.

‘The system is failing’, ‘the goals are only being achieved to a limited extent’, ‘we’re letting children down’. These are some of the newspaper headlines that followed the publication of a report by researchers from Leiden University in September. Commissioned by the Dutch Research and Documentation…

Moot Court

Prior to arriving to Leiden, Dr. Abazon completed her Ph.D. at Yale University's Department of Comparative Literature, where she also taught courses ranging from Introduction to Zionism to World Cinema.

Conference

When a child is placed in care, the assumption is always that the child can return home again. But there are still many questions about how this process – the 'permanency plan' – is arranged. New research aims to provide insights.

Leiden University and the Leiden Bio Science Park can make a significant contribution to the earning capacity of the Netherlands. This is the finding of the National Investment Agenda presented today.

Jasper Knoester is the dean of the Faculty of Science. How is he doing, what exactly does he do and what does his day look like? In each newsletter, Jasper gives an insight into his life.

Marlien van Mever delved into the analysis of tiny samples, cerebrospinal fluid from transgenic mouse models for example. She validated methods that can now be used to study brain diseases such as migraine and epilepsy. Van Mever will receive her PhD on 14 June.

A new class of polymers has been used in patients for the first time. The compound is the first new drug solubilising agent in decades. Introduced in 2014 by chemist Matthias Barz from Leiden University, it offers a unique alternative to current options.

During illness, the stiffness or viscosity of cells can change. Tom Evers demonstrated this by measuring such properties of human immune cells for the first time. ‘The stiffness of certain cells could be a way to make a diagnosis,’ Evers said. He defended his thesis on March 26th.

Joey Zuijdervelt

A staggering 6.5 billion chicks are killed worldwide every year. These are generally male chicks that are of no economic value. In Ovo has developed technology that can quickly determine the sex of a chick, to ensure that only female chicks are hatched. The first 150,000 chicks have now hatched in this…

'What nature made isn’t necessarily an optimized medicine to use in the human body,’ says Professor of Biological Chemistry Nathaniel Martin. That’s why a group of Leiden researchers is making a chemistry-based improved version of the frequently used antibiotic vancomycin. They received an NWO NACTAR…

Ten Leiden researchers have been awarded a Veni grant by the Dutch Research Council (NWO). The grant, of up to 280,000 euros, will enable them to elaborate their ideas over a period of three years.